JP2006527741A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006527741A5 JP2006527741A5 JP2006516231A JP2006516231A JP2006527741A5 JP 2006527741 A5 JP2006527741 A5 JP 2006527741A5 JP 2006516231 A JP2006516231 A JP 2006516231A JP 2006516231 A JP2006516231 A JP 2006516231A JP 2006527741 A5 JP2006527741 A5 JP 2006527741A5
- Authority
- JP
- Japan
- Prior art keywords
- hfddde
- hexapeptide
- active ingredient
- preventing
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000004480 active ingredient Substances 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 230000007170 pathology Effects 0.000 claims 1
- 239000008177 pharmaceutical agent Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20030923A FI20030923A7 (fi) | 2003-06-19 | 2003-06-19 | Leukosyytti-proMMP-9/beta2-integriinikompleksin inhibiittorit |
| FI20040616A FI20040616A0 (fi) | 2004-04-29 | 2004-04-29 | Solumigraation inhibiittorit |
| PCT/FI2004/000376 WO2004110478A1 (en) | 2003-06-19 | 2004-06-21 | Inhibitors of cell migration |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006527741A JP2006527741A (ja) | 2006-12-07 |
| JP2006527741A5 true JP2006527741A5 (enrdf_load_stackoverflow) | 2007-08-02 |
Family
ID=33553915
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006516231A Withdrawn JP2006527741A (ja) | 2003-06-19 | 2004-06-21 | 細胞遊走の阻害剤 |
| JP2006516230A Withdrawn JP2006527740A (ja) | 2003-06-19 | 2004-06-21 | 白血球におけるｐｒｏＭＭＰ−９／β２インテグリン複合体の阻害剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006516230A Withdrawn JP2006527740A (ja) | 2003-06-19 | 2004-06-21 | 白血球におけるｐｒｏＭＭＰ−９／β２インテグリン複合体の阻害剤 |
Country Status (3)
| Country | Link |
|---|---|
| EP (2) | EP1644032A1 (enrdf_load_stackoverflow) |
| JP (2) | JP2006527741A (enrdf_load_stackoverflow) |
| WO (2) | WO2004110477A1 (enrdf_load_stackoverflow) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008528023A (ja) * | 2005-01-31 | 2008-07-31 | フォンダツィオーネ セントロ サン ラファエレ デル モンテ タボール | ウロキナーゼプラスミノーゲンアクチベーター受容体由来の治療ペプチド |
| WO2007020405A2 (en) * | 2005-08-12 | 2007-02-22 | Cartela R & D Ab | Integrin i-domain binding peptides |
| GB2429012A (en) * | 2005-08-12 | 2007-02-14 | Cartela Ab | Polypeptides capable of binding an integrin I-domain. |
| EP2806028B1 (en) * | 2008-11-04 | 2017-07-12 | InDex Pharmaceuticals AB | Compounds and methods for reducing the recruitment and/or migration of polymorphonuclear cells |
| US8003110B1 (en) * | 2011-01-24 | 2011-08-23 | Matthias W. Rath | Metalloproteinase oligopeptides and their therapeutic use |
| CN110691606A (zh) * | 2017-03-22 | 2020-01-14 | 儿童医学中心公司 | Prss2抑制 |
| US11466080B2 (en) | 2017-03-22 | 2022-10-11 | Children's Medical Center Corporation | Methods of treating cancer using anti-LRP1 polyclonal antibodies |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5817750A (en) * | 1995-08-28 | 1998-10-06 | La Jolla Cancer Research Foundation | Structural mimics of RGD-binding sites |
| US20030022835A1 (en) * | 1998-04-29 | 2003-01-30 | Genesis Research And Development Corporation Limited | Compositions isolated from skin cells and methods for their use |
| GB9809764D0 (en) * | 1998-05-07 | 1998-07-08 | Isis Innovation | MMP-9 Gene polymorphisms |
| JP2003508352A (ja) * | 1999-07-13 | 2003-03-04 | ユニバーシティ・オブ・サザン・カリフォルニア | ＭＭＰ−９およびβ１インテグリンに基づくアンタゴニストを用いた血管形成の抑制のための新規な方法および組成物 |
| AU4347701A (en) * | 2000-03-01 | 2001-09-12 | Corixa Corp | Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| US7034134B2 (en) * | 2001-04-26 | 2006-04-25 | Bristol-Myers Squibb Company | Polynucleotide encoding a novel metalloprotease highly expressed in the testis, MMP-29 |
| WO2003091391A2 (en) * | 2002-04-23 | 2003-11-06 | Duke University | Atherosclerotic phenotype determinative genes and methods for using the same |
-
2004
- 2004-06-21 JP JP2006516231A patent/JP2006527741A/ja not_active Withdrawn
- 2004-06-21 EP EP04742119A patent/EP1644032A1/en not_active Withdrawn
- 2004-06-21 WO PCT/FI2004/000375 patent/WO2004110477A1/en not_active Ceased
- 2004-06-21 JP JP2006516230A patent/JP2006527740A/ja not_active Withdrawn
- 2004-06-21 EP EP04742118A patent/EP1644031A1/en not_active Withdrawn
- 2004-06-21 WO PCT/FI2004/000376 patent/WO2004110478A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1183014T3 (da) | Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse | |
| NO2017047I1 (no) | Tofacitinib, evt. i form av et farmasøytisk akseptabelt salt, inkludert citratsalt | |
| JP2004210767A5 (enrdf_load_stackoverflow) | ||
| JP2002532112A5 (enrdf_load_stackoverflow) | ||
| TNSN07304A1 (en) | Combination of xolair with immunosuppressive agent | |
| MX2009000730A (es) | Liberacion controlada de formulaciones y metodos asociados. | |
| WO2006035418A3 (en) | Microcapsules comprising a methylxanthine and a corticosteroid | |
| DE50313653D1 (de) | Wasserlösliche eisen-kohlenhydrat-komplexe, deren herstellung und diese enthaltende arzneimittel | |
| WO2004056337A3 (en) | Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats | |
| ZA200807767B (en) | Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient | |
| JP2002511411A5 (enrdf_load_stackoverflow) | ||
| PT1827396T (pt) | Medicamento oral de libertação modificada de pelo menos um princípio ativo sob forma multimicrocapsular | |
| UA88477C2 (ru) | Композиция пеллеты пролонгированного высвобождения, которая содержит прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение | |
| CL2004000416A1 (es) | Compuestos heterociclicos nitrogenados; composicion farmaceutica; y uso del compuesto para tratar o prevenir una condicion mediada por p38, que consiste en una enfermedad inflamatoria, autoinmune, virosica o neurodegenerativa. | |
| JP2007523135A5 (enrdf_load_stackoverflow) | ||
| EA200901393A1 (ru) | Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат | |
| JP2005509503A5 (enrdf_load_stackoverflow) | ||
| IL187575A (en) | Benzofuranyl derivatives ,pharmaceutical formulations comprising the same and use thereof in the preparation of medicaments for the treatment of 5-ht6-receptor related disorders | |
| DE60102590D1 (de) | Darreichungsformen zur behandlung von oralen mykosen | |
| ITMI20021725A1 (it) | Composizioni farmaceutiche ad attivita' antibiotica. | |
| ITRM20030363A0 (it) | Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse. | |
| JP2006527741A5 (enrdf_load_stackoverflow) | ||
| JP2008515980A5 (enrdf_load_stackoverflow) | ||
| IS8430A (is) | Lyf sem inniheldur (2R)-2-própýloktansýru sem virka efnisþáttinn | |
| EP1731609A4 (en) | INHIBITOR OF THE EXPRESSION OF RAD51, MEDICAMENT CONTAINING THE INHIBITOR AS ACTIVE INGREDIENT AND USE THEREOF |